SHINE Technologies and Nucleus RadioPharma are partnering to advance radioligand cancer treatments, SHINE announced recently. “We are proud to partner with Nucleus RadioPharma to supply the high-purity lutetium-177 that powers…
Cellectar Biosciences is partnering with Florida Cancer Specialists & Research Institute (FCS) to advance patient care and further define the U.S. treatment landscape, the company announced today. According to a…
Stem Pharm announced recently that it has been awarded a Small Business Innovation Research (SBIR) grant from the National Institutes of Health (NIH) to advance a groundbreaking model of Alzheimer’s…
SHINE Technologies has raised $70 million in additional funding to accelerate the commercialization of near-term applications of fusion technology, the company announced today. The round was led by existing investors…
Promega announced today that it is collaborating with GSK, a global biopharma company, to plan, develop and commercialize a microsatellite instability (MSI) companion diagnostic (CDx) IVD kit. According to a…
BioForward announced recently the recipients of its ninth annual Wisconsin Biohealth Awards, which recognize exceptional scientific and business accomplishments within the state’s biohealth industry. Dr. Thomas Grist, the chair of…
Exact Sciences announced today that it acquired Resolution Bioscience from Agilent Technologies. According to a release, Resolution Bioscience’s blood-based diagnostic tests complement Exact Sciences’ Precision Oncology portfolio, providing a more…
Cellectar Biosciences has closed its $103 million private placement financing, the company announced today. According to a release, the financing was led by Rosalind Advisors with participation from AIGH Capital,…
NorthStar Medical Radioisotopes has established a partnership with Curadh MTR Inc., a global molecularly targeted radiation (MTR)-focused organization, the company announced recently. According to a release, NorthStar will supply its…
NorthStar Medical Radioisotopes announced today the first patient to be treated using the radioisotope Copper-67 (Cu-67) produced from its electron accelerator. According to a release, the administration of the therapeutic…
